Answers are grounded in this paper and cite their sources.
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder with impairment in social interaction, communication and restrictive, repetitive behaviours and interests. Considering limited genetic research on ASD in India, we are uncertain of whether its architecture is similar or dissimilar to what is observed globally. Therefore, utilizing SFARI- a well-curated database of ASD-associated genes, we investigated their mutation burden among Indian ASD subjects and studied the impact of variant stratification across populations. For this purpose, Whole Exome Sequencing and analysis was performed for 25 Indian ASD subjects. The findings revealed that only 15% of SFARI genes carried 241 common and rare deleterious variations in our ASD cohort. The most frequent variants were Protein Truncating Variants (PTVs) (69.7%). SFARI score-1 genes had more missense variants than PTVs, hinting at their evolutionarily conserved nature. Seven PTVs in genes, SON , KMT2C , EXOC6B, RBFOX1, CAPN12 and KIZ were found to be altered in multiple ASD individuals. Notably, 32% of 241 deleterious variations identified were common across populations. The Asian population had significantly greater proportion of rare PTVs than the global population (p-value < 0.0071). Multidimensional functional analysis identified 101 genes with neurodevelopmental functions, of which, six genes were altered in unrelated ASD subjects globally which could be potential new ASD-candidate genes. Overall, our study provides evidence that an increased rate of PTVs burdens Indian ASD subjects and common variants levy additional genetic risk. Further, using population-specific human genome reference is essential to obtain meaningful insights into population-specific risks for disease.
No takes yet. Share an insight, caveat, or question.
RameshRaju et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: